Search the Newsreel

Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A

Ariel Investments, LLC has disclosed a significant stake in Core Laboratories Inc. common stock through a Schedule 13G/A filing. The investment firm beneficially owns 14,074,945 shares, which accounts for 30.5% of the outstanding common stock as of June 30, 2026. This includes sole voting …

Labcorp announces executive leadership changes effective in September

Labcorp (NYSE:LH) has announced executive leadership changes effective in September. Megan D. Bailey is resigning as Executive Vice President and President, Central Laboratories and International, effective September 4, 2026. Brian J. Caveney, M.D., will assume an expanded role as Executive Vice President and President, …

5 Revealing Analyst Questions From Taboola’s Q2 Earnings Call

5 Revealing Analyst Questions From Taboola's Q2 Earnings Call Taboola's second quarter was met with a negative market response as revenue fell short of Wall Street expectations. Management attributed the shortfall primarily to two factors: a Google policy change that discontinued the "Explore More" …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Taboola.com Ltd. (TBLA) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Taboola.com Ltd. (TBLA) after its stock price dropped significantly following a disappointing Q2 2026 earnings report. The company reported revenue below guidance and attributed this to exiting certain publisher relationships. Investors who purchased Taboola.com …

3 Oil & Gas Drilling Stocks Bucking a Bearish Industry Trend

Despite a bearish industry outlook, the Oil and Gas - Drilling sector has seen strong performance over the past year, with a 68.9% gain. This article highlights Patterson-UTI Energy (PTEN), Nabors Industries (NBR), and Helmerich & Payne (HP) as standout companies. These companies are …

Earnings call transcript: Ipca Laboratories beats Q1 2026 estimates, lifts outlook

Alkem Laboratories trading window opens on August 17

Alkem Laboratories Shares Fall Over 2% Amidst Bearish Sentiment

Alkem Laboratories net profit falls 21% in Q1FY27 to ₹5,209.8 million

Thompson Investment Management Inc. Has $1.28 Million Stock Position in Abbott Laboratories $ABT

Toth Financial Advisory Corp Decreases Stock Holdings in Abbott Laboratories $ABT

Wedge Capital Management L L P NC Acquires 26,860 Shares of Dolby Laboratories $DLB

Alkem Laboratories Q1 results: Net profit drops 21% YoY; board approves setting up new block at Baddi plant

Abbott Laboratories $ABT Shares Sold by Cox Capital Mgt LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Silicon Laboratories, Inc. (NASDAQ:SLAB) Given Average Rating of "Reduce" by Brokerages

Silicon Laboratories, Inc. (NASDAQ:SLAB) has received an average "Reduce" rating from six brokerages, with an average 12-month price target of $218. The company recently reported quarterly adjusted EPS of $0.71 on revenue of $228.19 million, surpassing analyst expectations. Despite insider selling by the CEO, …

IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IDEXX Laboratories Inc (IDXX), focusing on its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock has a momentum score of 3.37, trading between a resistance of 605.29 and support …

5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call

5 Insightful Analyst Questions From Charles River Laboratories's Q2 Earnings Call Charles River Laboratories' second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management highlighted that the rebound was most evident in the Discovery and Safety Assessment (DSA) …

Ipca Laboratories shares fall over 2%; strong financial performance reported

Neuland Lab Consolidated June 2026 Net Sales at Rs 641.58 crore, up 119.15% Y-o-Y

Brooks Laboratories reports consolidated net loss of Rs 1.79 crore in the June 2026 quarter

Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale

An executive at Abbott Laboratories (ABT), Louis H. Morrone, recently sold 5,850 shares of company stock for $642,505. This insider transaction provides investors with additional data to consider regarding the company's current valuation. Abbott's stock performance and analyst ratings are influenced by its strong …

Grove (GROV) Q2 2026 Earnings Call Transcript

Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?

When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma …

Taboola Stock And Other Penny Shares With Strong Balance Sheets

This article identifies penny stocks with strong balance sheets using the "Financially Fit Penny Stocks" screener. It highlights three companies: Taboola.com (TBLA), focusing on AI-driven ad platforms; Clover Health Investments (CLOV), operating in Medicare Advantage with AI support; and Hyliion Holdings (HYLN), developing a …

Birgit Girshick Sells 6,500 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Birgit Girshick, CEO of Charles River Laboratories International (NYSE:CRL), sold 6,500 shares of the company's stock for approximately $1.82 million. This transaction, executed under a Rule 10b5-1 trading plan, reduced her ownership by 15.29%. The company recently reported strong quarterly EPS and revenue that …

Charles River Laboratories International (NYSE:CRL) EVP Sells $1,038,657.24 in Stock

Charles River Laboratories International's EVP, Shannon Parisotto, sold 3,714 shares of company stock for approximately $1.04 million, reducing her holdings by 43.59%. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. The company recently reported adjusted earnings of $3.02 per share, exceeding estimates, …

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors

Charles River Laboratories International Inc. (CRL) stock fell 1.09% to $281.27 on Thursday, despite a positive trading session for the broader market. This underperformance snapped a seven-day winning streak for the company's shares. The S&P 500 Index rose 0.65%, and the Dow Jones Industrial …

Charles River Labs (CRL) CEO exercises 6,500 options and sells shares under 10b5-1 plan

Charles River Laboratories (CRL) CEO Birgit Girshick exercised stock options for 6,500 shares on August 11, 2026, at an exercise price of $179.66 per share. Simultaneously, she sold these 6,500 common shares at $279.90 per share. These transactions were conducted under a pre-arranged Rule …

Charles River (CRL) executive Parisotto exercises options, sells 3,714 shares under 10b5-1 plan

Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories International, exercised stock options for 3,714 shares at $179.66 per share and simultaneously sold the same number of shares at $279.66 per share. These transactions, executed on August 11, 2026, were conducted …

CABOT CORP - NOTES SOLD AT 99.993% OF FACE AMOUNT

Cabot Corp. has sold notes at 99.993% of their face amount. The article is a brief news announcement from Reuters, indicating a financial transaction by the company. Further details require logging into the platform where the article is hosted.

Wellington group discloses 2.4M Cabot Corporation (CBT) shares under management

Wellington Management Group LLP and its related entities have updated their ownership report for Cabot Corporation (CBT), disclosing beneficial ownership of 2,416,471 shares, which represents 4.68% of the common stock. The filing indicates shared voting power over 1,870,169 shares and shared dispositive power over …

Reabold Resources (LSE:RBD) Tests Whether corporate activity in a low-priced natural-resources share Can Endure

Invesco reports 2.98M-share stake in Charles River Laboratories (CRL)

Invesco Ltd., a Bermuda-based parent holding company, has reported a significant passive ownership position in Charles River Laboratories International, Inc. (CRL) common stock. The firm beneficially owns 2,984,785 shares, representing 6.2% of the outstanding common stock, held by its investment advisory clients. Invesco maintains …

Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High - Here's Why

Silicon Labs Q2 FY 2026: IoT Recovery Builds Momentum for Series 3 Platform

Silicon Labs reported strong Q2 FY 2026 earnings, showing sequential improvements in revenue, gross margin, and profitability, indicating a recovery in the IoT semiconductor sector. The company's new 22nm Series 3 platform is central to its strategy of moving into more complex, compute-heavy, and …

Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice

Johnson Rice upgraded Core Laboratories (NYSE:CLB) from a "hold" to a "buy" rating, setting a $21.00 price target. This upgrade implies a significant upside, although the broader analyst consensus remains "Hold." The company recently reported better-than-expected EPS but missed revenue estimates, while its CEO …